In the last 12 months, insiders at Cellectar Biosciences, Inc. ($CLRB) filed 44 transactions with the SEC: 7 open-market purchases totaling $133,150 and 1 sales totaling $732. Net insider sentiment: net buying.
Cellectar Biosciences, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Longcor Jarrod (Chief Operating Officer) — 8 transactions totaling $58,300
- CARUSO JAMES V (Chief Executive Officer) — 2 transactions totaling $49,900
- Kolean Chad J (Chief Financial Officer) — 7 transactions totaling $24,950
- NEIS JOHN (Director) — 4 transactions totaling $732
- CARUSO JAMES V (President and CEO) — 5 transactions totaling $0
View all SEC Filings for Cellectar Biosciences, Inc. (CLRB).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 12, 2025 | NEIS JOHN | Director | S | Common Stock | 198 | $3.70 | 10.0000 | 3,162,040 | 95.19% | 0.01% |
| July 2, 2025 | CARUSO JAMES V | Chief Executive Officer | P | Common Stock | 10000 | $4.99 | 11,638.0000 | 1,608,799 | 610.50% | 0.62% |
| July 2, 2025 | Longcor Jarrod | Chief Operating Officer | P | Warrants | 10000 | $0.01 | 10,000.0000 | 1,608,799 | 9999.99% | 0.62% |
| July 2, 2025 | Kolean Chad J | Chief Financial Officer | P | Common Stock | 5000 | $4.99 | 6,418.0000 | 1,608,799 | 352.61% | 0.31% |
| July 2, 2025 | Kolean Chad J | Chief Financial Officer | P | Warrants | 5000 | $0.01 | 5,000.0000 | 1,608,799 | 9999.99% | 0.31% |
| July 2, 2025 | Longcor Jarrod | Chief Operating Officer | P | Common Stock | 10000 | $4.99 | 12,768.0000 | 1,608,799 | 361.27% | 0.62% |
| July 2, 2025 | CARUSO JAMES V | Chief Executive Officer | P | Warrants | 10000 | $0.01 | 10,000.0000 | 1,608,799 | 9999.99% | 0.62% |
| Jan. 10, 2025 | Longcor Jarrod | Chief Operating Officer | P | Common Stock | 30000 | $0.28 | 83,141.0000 | 1,238,125 | 56.45% | 2.42% |
| Feb. 14, 2025 | Loren Stefan | Director | A | Stock option (right to buy) | 60000 | $0.00 | 60,000.0000 | 1,238,125 | 9999.99% | 4.85% |
| Feb. 14, 2025 | Longcor Jarrod | Chief Operating Officer | A | Stock option (right to buy) | 500000 | $0.00 | 500,000.0000 | 1,238,125 | 9999.99% | 40.38% |
| Feb. 14, 2025 | Kolean Chad J | Chief Financial Officer | A | Stock option (right to buy) | 290000 | $0.00 | 290,000.0000 | 1,238,125 | 9999.99% | 23.42% |
| Feb. 14, 2025 | DRISCOLL FREDERICK W | Director | A | Stock option (right to buy) | 60000 | $0.00 | 60,000.0000 | 1,238,125 | 9999.99% | 4.85% |
| Feb. 14, 2025 | Chanan-Khan Asher | Director | A | Stock option (right to buy) | 60000 | $0.00 | 60,000.0000 | 1,238,125 | 9999.99% | 4.85% |
| Feb. 14, 2025 | CARUSO JAMES V | President and CEO | A | Stock option (right to buy) | 900000 | $0.00 | 900,000.0000 | 1,238,125 | 9999.99% | 72.69% |
| Feb. 14, 2025 | NEIS JOHN | Director | A | Stock option (right to buy) | 60000 | $0.00 | 60,000.0000 | 1,238,125 | 9999.99% | 4.85% |
| Feb. 14, 2025 | Swirsky Douglas J | Director | A | Stock option (right to buy) | 90000 | $0.00 | 90,000.0000 | 1,238,125 | 9999.99% | 7.27% |
| June 14, 2024 | Kolean Chad J | Chief Financial Officer | A | Stock option (right to buy) | 290000 | $0.00 | 290,000.0000 | 29,346,679 | 9999.99% | 0.99% |
| June 14, 2024 | Longcor Jarrod | Chief Operating Officer | A | Stock option (right to buy) | 500000 | $0.00 | 500,000.0000 | 29,346,679 | 9999.99% | 1.70% |
| June 14, 2024 | CARUSO JAMES V | President and CEO | A | Stock option (right to buy) | 900000 | $0.00 | 900,000.0000 | 29,346,679 | 9999.99% | 3.07% |
| June 14, 2024 | Shustov Andrei | Senior Vice President, Medical | A | Stock option (right to buy) | 260000 | $0.00 | 260,000.0000 | 29,346,679 | 9999.99% | 0.89% |
| June 14, 2024 | Lea Darrell Shane | Chief Commercial Officer | A | Stock option (right to buy) | 260000 | $0.00 | 260,000.0000 | 29,346,679 | 9999.99% | 0.89% |
| June 14, 2024 | Loren Stefan | Director | A | Stock option (right to buy) | 60000 | $0.00 | 60,000.0000 | 29,346,679 | 9999.99% | 0.20% |
| June 14, 2024 | Swirsky Douglas J | Director | A | Stock option (right to buy) | 90000 | $0.00 | 90,000.0000 | 29,346,679 | 9999.99% | 0.31% |
| June 14, 2024 | NEIS JOHN | Director | A | Stock option (right to buy) | 60000 | $0.00 | 60,000.0000 | 29,346,679 | 9999.99% | 0.20% |
| June 14, 2024 | DRISCOLL FREDERICK W | Director | A | Stock option (right to buy) | 60000 | $0.00 | 60,000.0000 | 29,346,679 | 9999.99% | 0.20% |
| June 14, 2024 | Chanan-Khan Asher | Director | A | Stock option (right to buy) | 60000 | $0.00 | 60,000.0000 | 29,346,679 | 9999.99% | 0.20% |
| June 23, 2023 | Lea Darrell Shane | Chief Commercial Officer | A | Stock option (right to buy) | 100000 | $0.00 | 100,000.0000 | 11,261,217 | 9999.99% | 0.89% |
| Dec. 8, 2023 | Kolean Chad J | Chief Financial Officer | A | Common Stock | 42554 | $0.00 | 42,578.0000 | 11,308,738 | 9999.99% | 0.38% |
| June 23, 2023 | Kolean Chad J | Chief Financial Officer | A | Stock option (right to buy) | 104000 | $0.00 | 104,000.0000 | 11,261,217 | 9999.99% | 0.92% |
| Dec. 8, 2023 | Shustov Andrei | Senior Vice President, Medical | A | Common Stock | 47856 | $0.00 | 55,037.7000 | 11,308,738 | 666.36% | 0.42% |
| Dec. 8, 2023 | Lea Darrell Shane | Chief Commercial Officer | A | Common Stock | 39599 | $0.00 | 39,599.0000 | 11,308,738 | 9999.99% | 0.35% |
| Dec. 8, 2023 | Longcor Jarrod | Chief Operating Officer | A | Common Stock | 42927 | $0.00 | 53,141.0000 | 11,308,738 | 420.28% | 0.38% |
| June 23, 2023 | Longcor Jarrod | Chief Operating Officer | A | Stock option (right to buy) | 144000 | $0.00 | 144,000.0000 | 11,261,217 | 9999.99% | 1.28% |
| Dec. 8, 2023 | CARUSO JAMES V | President and CEO | A | Common Stock | 40596 | $0.00 | 49,236.0000 | 11,308,738 | 469.86% | 0.36% |
| June 23, 2023 | CARUSO JAMES V | President and CEO | A | Stock option (right to buy) | 261000 | $0.00 | 261,000.0000 | 11,261,217 | 9999.99% | 2.32% |
| June 28, 2023 | NEIS JOHN | Director | A | Stock option (right to buy) | 25000 | $0.00 | 47,887.0000 | 11,261,217 | 109.23% | 0.22% |
| June 28, 2023 | Swirsky Douglas J | Director | A | Stock option (right to buy) | 37500 | $0.00 | 71,925.0000 | 11,261,217 | 108.93% | 0.33% |
| June 28, 2023 | Loren Stefan | Director | A | Stock option (right to buy) | 25000 | $0.00 | 47,885.0000 | 11,261,217 | 109.24% | 0.22% |
| June 28, 2023 | DRISCOLL FREDERICK W | Director | A | Stock option (right to buy) | 25000 | $0.00 | 47,650.0000 | 11,261,217 | 110.38% | 0.22% |
| June 28, 2023 | Chanan-Khan Asher | Director | A | Stock option (right to buy) | 25000 | $0.00 | 40,600.0000 | 11,261,217 | 160.26% | 0.22% |
| Feb. 15, 2023 | Shustov Andrei | Senior Vice President, Medical | A | Stock option (right to buy) | 100000 | $0.00 | 100,000.0000 | 7,055,665 | 9999.99% | 1.42% |
| Jan. 17, 2023 | Longcor Jarrod | Chief Operating Officer | A | Stock option (right to buy) | 144000 | $0.00 | 144,000.0000 | 7,055,665 | 9999.99% | 2.04% |
| Jan. 17, 2023 | CARUSO JAMES V | President and CEO | A | Stock option (right to buy) | 261000 | $0.00 | 261,000.0000 | 7,055,665 | 9999.99% | 3.70% |
| Jan. 17, 2023 | Kolean Chad J | Chief Financial Officer | A | Stock option (right to buy) | 104000 | $0.00 | 104,000.0000 | 7,055,665 | 9999.99% | 1.47% |